Ron Kleiner

945 total citations
13 papers, 723 citations indexed

About

Ron Kleiner is a scholar working on Oncology, Biomedical Engineering and Immunology. According to data from OpenAlex, Ron Kleiner has authored 13 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Biomedical Engineering and 4 papers in Immunology. Recurrent topics in Ron Kleiner's work include Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ron Kleiner is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ron Kleiner collaborates with scholars based in Israel, Portugal and Italy. Ron Kleiner's co-authors include Ronit Satchi‐Fainaro, Eilam Yeini, Helena F. Florindo, Daniella Vaskovich‐Koubi, Galia Tiram, Rita C. Acúrcio, Bárbara Carreira, Yulia Liubomirski, Sabina Pozzi and Anna Scomparin and has published in prestigious journals such as Nature Communications, Nature Nanotechnology and Cancer Research.

In The Last Decade

Ron Kleiner

13 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Kleiner Israel 7 262 234 227 180 150 13 723
Bárbara Carreira Portugal 8 225 0.9× 247 1.1× 160 0.7× 185 1.0× 97 0.6× 12 765
Milad Shirvaliloo Iran 16 314 1.2× 134 0.6× 50 0.2× 151 0.8× 49 0.3× 43 701
Shan Guan China 19 796 3.0× 134 0.6× 156 0.7× 102 0.6× 149 1.0× 51 1.2k
Fu‐Fei Hsu Taiwan 11 316 1.2× 117 0.5× 161 0.7× 87 0.5× 113 0.8× 15 636
Dipika Nandi United States 11 205 0.8× 220 0.9× 363 1.6× 84 0.5× 117 0.8× 14 647
Ziyun Gao China 12 408 1.6× 99 0.4× 46 0.2× 52 0.3× 66 0.4× 24 676
Marcela D Salazar United States 10 223 0.9× 72 0.3× 61 0.3× 61 0.3× 153 1.0× 13 558
Enguo Chen China 12 297 1.1× 305 1.3× 148 0.7× 43 0.2× 137 0.9× 44 756
Ashlesha Deshpande United States 15 266 1.0× 42 0.2× 200 0.9× 158 0.9× 83 0.6× 33 725

Countries citing papers authored by Ron Kleiner

Since Specialization
Citations

This map shows the geographic impact of Ron Kleiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Kleiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Kleiner more than expected).

Fields of papers citing papers by Ron Kleiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Kleiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Kleiner. The network helps show where Ron Kleiner may publish in the future.

Co-authorship network of co-authors of Ron Kleiner

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Kleiner. A scholar is included among the top collaborators of Ron Kleiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Kleiner. Ron Kleiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Vaskovich‐Koubi, Daniella, et al.. (2025). Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment Challenges. Advanced Drug Delivery Reviews. 225. 115670–115670. 1 indexed citations
2.
Dey, Pradip, Ron Kleiner, Sabina Pozzi, et al.. (2024). Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers. Science Advances. 10(50). eadr4762–eadr4762. 4 indexed citations
3.
Kleiner, Ron, et al.. (2024). Abstract 5551: Targeted nanoparticles co-delivering PARP inhibitor and other immune modulators overcome the immunosuppressive tumor microenvironment. Cancer Research. 84(6_Supplement). 5551–5551. 1 indexed citations
4.
Yeini, Eilam, Daniella Vaskovich‐Koubi, Ron Kleiner, Helena F. Florindo, & Ronit Satchi‐Fainaro. (2023). Abstract 3243: Modulating the brain immune system to fight cancer in 3 dimensions. Cancer Research. 83(7_Supplement). 3243–3243. 1 indexed citations
5.
Peres, Carina, Ana I. Matos, Liane I.F. Moura, et al.. (2021). Preclinical models and technologies to advance nanovaccine development. Advanced Drug Delivery Reviews. 172. 148–182. 33 indexed citations
6.
Pozzi, Sabina, Anna Scomparin, Paula Ofek, et al.. (2021). Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?. Advanced Drug Delivery Reviews. 175. 113760–113760. 48 indexed citations
7.
Yeini, Eilam, Paula Ofek, Sabina Pozzi, et al.. (2021). P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression. Nature Communications. 12(1). 1912–1912. 56 indexed citations
8.
Vaskovich‐Koubi, Daniella, Ron Kleiner, Yulia Liubomirski, et al.. (2021). Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19. Cancer Research. 81(13_Supplement). 714–714. 1 indexed citations
9.
Yeini, Eilam, Paula Ofek, Lena Neufeld, et al.. (2020). Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches. Advanced Therapeutics. 4(1). 54 indexed citations
10.
Florindo, Helena F., Ron Kleiner, Daniella Vaskovich‐Koubi, et al.. (2020). Immune-mediated approaches against COVID-19. Nature Nanotechnology. 15(8). 630–645. 249 indexed citations
11.
Carreira, Bárbara, Rita C. Acúrcio, Ana I. Matos, et al.. (2020). Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment. Advanced Therapeutics. 4(1). 5 indexed citations
12.
Conniot, João, Anna Scomparin, Carina Peres, et al.. (2019). Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nature Nanotechnology. 14(9). 891–901. 187 indexed citations
13.
Poley, Maria, Assaf Zinger, Nitzan Krinsky, et al.. (2019). Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells. Journal of Controlled Release. 307. 331–341. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bárbara Carreira Breakdown of academic impact, for papers by Milad Shirvaliloo Breakdown of academic impact, for papers by Shan Guan Breakdown of academic impact, for papers by Fu‐Fei Hsu Breakdown of academic impact, for papers by Dipika Nandi Breakdown of academic impact, for papers by Ziyun Gao Breakdown of academic impact, for papers by Marcela D Salazar Breakdown of academic impact, for papers by Enguo Chen Breakdown of academic impact, for papers by Ashlesha Deshpande
Rankless by CCL
2026